1. Identification of CD318 (CDCP1) as novel prognostic marker in AML
   Jonas S. Heitmann et al, 2020, Annals of Hematology CrossRef
2. CD318 is a ligand for CD6
   Gospel Enyindah-Asonye et al, 2017, Proceedings of the National Academy of Sciences CrossRef
3. CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo
   Abdullah Alajati et al, 2020, Journal of Clinical Investigation CrossRef
4. Single-cell RNA-seq analysis identifies meniscus progenitors and reveals the progression of meniscus degeneration
   Hao Sun et al, 2020, Annals of the Rheumatic Diseases CrossRef
5. Cell-Surface Protein Profiling Identifies Distinctive Markers of Progenitor Cells in Human Skeletal Muscle
   Akiyoshi Uezumi et al, 2016, Stem Cell Reports CrossRef
6. CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer
   Ming Li et al, 2022, Clinical and Experimental Medicine CrossRef
7. Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry
   Monica Reis et al, 2018, Scientific Reports CrossRef
8. CEACAM1 is a novel culture-compatible surface marker of expanded long-term reconstituting hematopoietic stem cells
   Unain Ansari et al, 2022, Blood Advances CrossRef
9. The usefulness of three-dimensional cell culture in induction of cancer stem cells from esophageal squamous cell carcinoma cell lines
   Daisuke Fujiwara et al, 2013, Biochemical and Biophysical Research Communications CrossRef
10. Hepatic stem cells with self-renewal and liver repopulation potential are harbored in CDCP1-positive subpopulations of human fetal liver cells
    Ran-Ran Zhang et al, 2018, Stem Cell Research & Therapy CrossRef
11. Integrin-α3 Is a Functional Marker of Ex Vivo Expanded Human Long-Term Hematopoietic Stem Cells
    Elisa Tomellini et al, 2019, Cell Reports CrossRef
12. CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
    Miriam Saponaro et al, 2023, Scientific Reports CrossRef
13. CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
    Xiao Qi et al, 2022, Life Sciences CrossRef